Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory agencies are heading.

Years of stifling regulatory environments and political headwinds that have hampered the cannabis industry seem to be giving way to real progress.

Earlier this year, the United States Department of Health and Human Services (HHS) released a 252-page report stating that cannabis is safe. The health authority further noted that cannabis has true potential as a medicine that can help with symptomatic conditions for at least 15 medical indications. After decades of assertions that there is not enough evidence cannabis is safe and valuable as a medicine, this news is truly transformational for the industry.

Most reading this article have always known this. However, many people believed these hostile, politically motivated, and biased authorities were blocking hundreds of millions of people from access to safer medications. This publication from the HHS could and should herald a major shift.

Read the full article at Business of Cannabis